BioCentury
ARTICLE | Clinical News

Molecular Targeting regulatory update

August 17, 1998 7:00 AM UTC

Northeastern University (Boston, Mass.) received U.S. Patent No. 5,780,052 covering a gene therapy technology that prevents cell death by restoring the integrity of damaged cell membranes. Molecular T...